While GLP-1 medications have modest natriuretic effects in some studies, the primary concern is the secondary effects of reduced intake and increased gastrointestinal losses
Used in the right patient, with the right expectations and the right support, it is a valuable and evidence-based option for improving both metabolic and cardiovascular health.
But heres what the 2026 data shows: people who stop these medications regain about two-thirds of the weight within a year on average, and many say the hardest part is the food noise coming back
Without visibility into this stacking, you can overshoot your therapeutic window and experience unnecessary side effects
A simple log of what felt good and what didn't helps you spot those patterns faster
Rare: breast engorgement, glycosuria, hypomenorrhea2, kidney pain, oliguria, uterine hemorrhage2, uterine fibroids enlarged2